KEGG   DRUG: Dasabuvir - ombitasvir - paritaprevir -ritonavir mixtHelp
Entry
D10582            Mixture   Drug                                   

Name
Dasabuvir - ombitasvir - paritaprevir -ritonavir mixt;
Viekira pak (TN)
Product
Component
Dasabuvir sodium hydrate [DR:D10581], Ombitasvir [DR:D10576], Paritaprevir [DR:D10580], Ritonavir [DR:D00427]
Remark
ATC code: 
Activity
Antiviral
  Disease
Chronic hepatitis C virus infection [DS:H00413]
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AX Other antivirals
     J05AX66 Dasabuvir, ombitasvir, paritaprevir and ritonavir
      D10582  Dasabuvir - ombitasvir - paritaprevir -ritonavir mixt
USP drug classification [BR:br08302]
 Antivirals
  Anti-hepatitis C (HCV) Agents, Direct Acting
   Ombitasvir/Paritaprevir/Ritonavir/Dasabuvir
    D10582  Dasabuvir - ombitasvir - paritaprevir -ritonavir mixt
Antivirals [br08351.html]
 D10582
New drug approvals in the USA [br08319.html]
 New Molecular Entity and New Therapeutic Biological Product Approvals
  D10582
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D10582
Pharmacogenomic biomarkers in FDA drug labels [br08341.html]
 Polymorphisms and germline mutations
  D10582
BRITE hierarchy
Other DBs
PubChem: 
ChEBI: 
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system